These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 27693091

  • 1. Outcome of metastatic urothelial carcinoma treated by systemic chemotherapy: Prognostic factors based on real-world clinical practice in Japan.
    Abe T, Ishizaki J, Kikuchi H, Minami K, Matsumoto R, Harabayashi T, Sazawa A, Mochizuki T, Chiba S, Akino T, Murakumo M, Miyajima N, Tsuchiya K, Maruyama S, Murai S, Shinohara N.
    Urol Oncol; 2017 Feb; 35(2):38.e1-38.e8. PubMed ID: 27693091
    [Abstract] [Full Text] [Related]

  • 2. Impact of multimodal treatment on survival in patients with metastatic urothelial cancer.
    Abe T, Shinohara N, Harabayashi T, Sazawa A, Maruyama S, Suzuki S, Nonomura K.
    Eur Urol; 2007 Oct; 52(4):1106-13. PubMed ID: 17367917
    [Abstract] [Full Text] [Related]

  • 3. Second-Line Chemotherapy for Metastatic Urothelial Carcinoma: Importance of Lymph Node-Only Metastasis as a Prognostic Factor and Construction of a Prognostic Model.
    Salah S, Lee JL, Rozzi A, Kitamura H, Matsumoto K, Srinivas S, Morales-Barrera R, Carles J, Al-Wardat R, Al-Rabi K, Maakoseh M.
    Clin Genitourin Cancer; 2016 Jun; 14(3):255-60. PubMed ID: 26552764
    [Abstract] [Full Text] [Related]

  • 4. Outcome of metastasectomy for urothelial carcinoma: a multi-institutional retrospective study in Japan.
    Abe T, Kitamura H, Obara W, Matsumura N, Tsukamoto T, Fujioka T, Hara I, Murai S, Shinohara N, Nonomura K.
    J Urol; 2014 Apr; 191(4):932-6. PubMed ID: 24211599
    [Abstract] [Full Text] [Related]

  • 5. Nomogram-based Prediction of Overall Survival in Patients with Metastatic Urothelial Carcinoma Receiving First-line Platinum-based Chemotherapy: Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC).
    Necchi A, Sonpavde G, Lo Vullo S, Giardiello D, Bamias A, Crabb SJ, Harshman LC, Bellmunt J, De Giorgi U, Sternberg CN, Cerbone L, Ladoire S, Wong YN, Yu EY, Chowdhury S, Niegisch G, Srinivas S, Vaishampayan UN, Pal SK, Agarwal N, Alva A, Baniel J, Golshayan AR, Morales-Barrera R, Bowles DW, Milowsky MI, Theodore C, Berthold DR, Daugaard G, Sridhar SS, Powles T, Rosenberg JE, Galsky MD, Mariani L, RISC Investigators.
    Eur Urol; 2017 Feb; 71(2):281-289. PubMed ID: 27726966
    [Abstract] [Full Text] [Related]

  • 6. Long-Term Results and Prognostic Factors of Pulmonary Metastasectomy in Patients with Metastatic Transitional Cell Carcinoma.
    Luzzi L, Marulli G, Solli P, Cardillo G, Ghisalberti M, Mammana M, Carleo F, Spaggiari L, Rea F.
    Thorac Cardiovasc Surg; 2017 Oct; 65(7):567-571. PubMed ID: 27148929
    [Abstract] [Full Text] [Related]

  • 7. Oncologic Outcome of Metastasectomy for Urothelial Carcinoma: Who Is the Best Candidate?
    Nakagawa T, Taguchi S, Kanatani A, Kawai T, Ikeda M, Urakami S, Matsumoto A, Komemushi Y, Miyakawa J, Yamada D, Suzuki M, Enomoto Y, Nishimatsu H, Kondo Y, Nagase Y, Hirano Y, Okaneya T, Tanaka Y, Miyazaki H, Fujimura T, Fukuhara H, Kume H, Igawa Y, Homma Y.
    Ann Surg Oncol; 2017 Sep; 24(9):2794-2800. PubMed ID: 28687875
    [Abstract] [Full Text] [Related]

  • 8. Posttreatment prognostic nomogram for patients with metastatic urothelial cancer completing first-line cisplatin-based chemotherapy.
    Galsky MD, Moshier E, Krege S, Lin CC, Hahn N, Ecke T, Sonpavde G, Pond G, Godbold J, Oh WK, Bamias A.
    Urol Oncol; 2014 Jan; 32(1):48.e1-8. PubMed ID: 24055428
    [Abstract] [Full Text] [Related]

  • 9. Prognostic impact of local radiotherapy on metastatic urothelial carcinoma patients receiving systemic chemotherapy.
    Abe T, Minami K, Harabayashi T, Sazawa A, Chiba H, Kikuchi H, Miyata H, Frumido J, Matsumoto R, Osawa T, Junji I, Tango M, Satoshi C, Tomoshige A, Masashi M, Naoto M, Kunihiko T, Satoru M, Murai S, Shinohara N.
    Jpn J Clin Oncol; 2020 Feb 17; 50(2):206-213. PubMed ID: 31665467
    [Abstract] [Full Text] [Related]

  • 10. Real-life clinical practice results with vinflunine in patients with relapsed platinum-treated metastatic urothelial carcinoma: an Italian multicenter study (MOVIE-GOIRC 01-2014).
    Passalacqua R, Lazzarelli S, Donini M, Montironi R, Tambaro R, De Giorgi U, Pignata S, Palumbo R, Ceresoli GL, Del Conte G, Tonini G, Morelli F, Nolè F, Panni S, Rondini E, Guida A, Zucali PA, Doni L, Iezzi E, Caminiti C.
    BMC Cancer; 2017 Jul 19; 17(1):493. PubMed ID: 28724419
    [Abstract] [Full Text] [Related]

  • 11. Prognostic model to predict survival in patients with metastatic upper tract urothelial carcinoma treated with cisplatin-based chemotherapy.
    Hsieh MC, Su YL, Chiang PH, Rau KM, Chen YY, Huang CH.
    Int J Urol; 2016 May 19; 23(5):385-9. PubMed ID: 26992082
    [Abstract] [Full Text] [Related]

  • 12. Outcome and prognostic factors in metastatic urothelial carcinoma patients receiving second-line chemotherapy: an analysis of real-world clinical practice data in Japan.
    Matsumoto R, Abe T, Ishizaki J, Kikuchi H, Harabayashi T, Minami K, Sazawa A, Mochizuki T, Akino T, Murakumo M, Osawa T, Maruyama S, Murai S, Shinohara N.
    Jpn J Clin Oncol; 2018 Aug 01; 48(8):771-776. PubMed ID: 29939285
    [Abstract] [Full Text] [Related]

  • 13. Impact of Primary Tumor Location on Survival from the European Organization for the Research and Treatment of Cancer Advanced Urothelial Cancer Studies.
    Moschini M, Shariat SF, Rouprêt M, De Santis M, Bellmunt J, Sternberg CN, Tombal B, Collette L.
    J Urol; 2018 May 01; 199(5):1149-1157. PubMed ID: 29158104
    [Abstract] [Full Text] [Related]

  • 14. Second-line Chemotherapy in Older Patients With Metastatic Urothelial Carcinoma: Pooled Analysis of 10 Second-line Studies.
    Salah S, Lee JL, Rozzi A, Kitamura H, Matsumoto K, Vis DJ, Srinivas S, Morales-Barrera R, Carles J, Al-Rimawi D, Lee S, Kim KH, Izumi K, Lewin J.
    Clin Genitourin Cancer; 2017 Aug 01; 15(4):e563-e571. PubMed ID: 28065418
    [Abstract] [Full Text] [Related]

  • 15. Is there a role for pulmonary metastasectomy with a curative intent in patients with metastatic urinary transitional cell carcinoma?
    Matsuguma H, Yoshino I, Ito H, Goya T, Matsui Y, Nakajima J, Ikeda N, Okumura S, Shiono S, Nomori H, Metastatic Lung Tumor Study Group of Japan.
    Ann Thorac Surg; 2011 Aug 01; 92(2):449-53. PubMed ID: 21801905
    [Abstract] [Full Text] [Related]

  • 16. The comparison of oncologic outcomes between metastatic upper tract urothelial carcinoma and urothelial carcinoma of the bladder after cisplatin-based chemotherapy.
    Hsieh MC, Chiang PH, Rau KM, Chen YY, Su YL, Huang CH.
    Urol Oncol; 2015 Nov 01; 33(11):495.e9-495.e14. PubMed ID: 26254698
    [Abstract] [Full Text] [Related]

  • 17. Current status of systemic chemotherapy for octogenarians with advanced urothelial cancer in Japan: a Japanese multi-institutional study (CURE study).
    Matsui Y, Ogawa O, Ishitsuka R, Miyazaki J, Inoue T, Kageyama S, Sugimoto M, Mitsuzuka K, Shiraishi Y, Kinoshita H, Wakeda H, Nomoto T, Kikuchi E, Fujie K, Keino N, Nishiyama H.
    Int J Clin Oncol; 2016 Dec 01; 21(6):1142-1149. PubMed ID: 27349431
    [Abstract] [Full Text] [Related]

  • 18. Skeletal Muscle Mass Reduction Velocity as a Simple Prognostic Indicator for Patients with Metastatic Urothelial Carcinoma Receiving Second-Line Chemotherapy.
    Nagai T, Naiki T, Iida K, Nozaki S, Etani T, Sugiyama Y, Ando R, Yanase T, Chaya R, Moritoki Y, Kobayashi D, Akita H, Okamura T, Yasui T.
    Asian Pac J Cancer Prev; 2019 Oct 01; 20(10):2995-3000. PubMed ID: 31653146
    [Abstract] [Full Text] [Related]

  • 19. Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.
    Saxman SB, Propert KJ, Einhorn LH, Crawford ED, Tannock I, Raghavan D, Loehrer PJ, Trump D.
    J Clin Oncol; 1997 Jul 01; 15(7):2564-9. PubMed ID: 9215826
    [Abstract] [Full Text] [Related]

  • 20. Impact of Prior Platinum-Based Therapy on Patients Receiving Salvage Systemic Treatment for Advanced Urothelial Carcinoma.
    Sonpavde G, Pond GR, Di Lorenzo G, Buonerba C, Rozzi A, Lanzetta G, Necchi A, Giannatempo P, Raggi D, Matsumoto K, Choueiri TK, Mullane S, Niegisch G, Albers P, Lee JL, Kitamura H, Kume H, Bellmunt J.
    Clin Genitourin Cancer; 2016 Dec 01; 14(6):494-498. PubMed ID: 27262369
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.